Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Shares of Novavax rose nearly 1% after the open on Friday, continuing a positive streak with gains expected for the third ...

Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $9.02 which represents a slight increase of $0.20 or 2.27% from the prior close of $8.82. The stock opened at $8.77 and touched a low of ...

Novavax (NVAX) announced progress in Q4 advancing its corporate growth strategy through its partnership with Sanofi (SNY). The company has ...

In the chaotic early days of the pandemic, Wall Street scrambled to place bets on the companies that looked the most likely ...

The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates ...

On Tuesday, Novavax Inc (NVAX) stock saw a decline, ending the day at $8.77 which represents a decrease of $-0.30 or -3.31% from the prior close of $9.07. The stock opened at $9.1 and touched a low of ...

The results of a clinical trial into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers ...

Shares of Novavax Inc. NVAX slid 3.31% to $8.77 Tuesday, on what proved to be an all-around poor trading session for the ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

Novavax (NVAX) announced that the first participants have been dosed in its COVID-19-Influenza Combination and stand-alone seasonal influenza ...

On CNBC's “ Mad Money Lightning Round ,” Jim Cramer said he is ‘not a fan' of Novavax, Inc. NVAX. On Dec. 4, Novavax agreed ...